Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 6, 2005, Pages 1567-1572

  Bennett Guerrero, Elliott ^a,c   Slaughter, Thomas F ^b   White, William D ^a   Welsby, Ian J ^a   Greenberg, Charles S ^a   El Moalem, Habib ^a   Ortel, Thomas L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEPARIN; HEPARIN ANTIBODY; THROMBOCYTE FACTOR 4; THROMBOCYTE FACTOR 4 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART SURGERY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VALIDATION PROCESS;

AGED; ANTIBODIES; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; PLATELET FACTOR 4; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 27944435286     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.07.052     Document Type: Article

References (20)

1. D.T. Mangano Aspirin and mortality from coronary bypass surgery N Engl J Med 347 2002 1309 1317
2. J.T. Walls, J.J. Curtis, D. Silver, T.M. Boley, R.A. Schmaltz, W. Nawarawong Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition Ann Thorac Surg 53 1992 787 791
3. G.R. Bernard, J.L. Vincent, P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
4. G. Cella, O. Vittadello, V. Gallucci, A. Girolami The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery Eur J Clin Invest 11 1981 165 169
5. T.F. Slaughter, C.S. Greenberg Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management Anesthesiology 87 1997 667 675
6. T.E. Warkentin, J.G. Kelton Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 2001 1286 1292
7. B.H. Chong Heparin-induced thrombocytopenia Br J Haematol 89 1995 431 439
8. J.L. Francis, G.J. Palmer III, R. Moroose, A. Drexler Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery Ann Thorac Surg 75 2003 17 22
9. C. Pouplard, M.A. May, S. Iochmann Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia Circulation 99 1999 2530 2536
10. T.L. Bauer, G. Arepally, B.A. Konkle Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242 1246
11. G.P. Visentin, M. Malik, K.A. Cyganiak, R.H. Aster Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes J Lab Clin Med 128 1996 376 383
12. M. Trossaert, A. Gaillard, P.L. Commin, J. Amiral, A.M. Vissac, E. Fressinaud High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery Br J Haematol 101 1998 653 655
13. E. Lindhoff-Last, F. Gerdsen, H. Ackermann, R. Bauersachs Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia Br J Haematol 113 2001 886 890
14. V. Parsonnet, D. Dean, A.D. Bernstein A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease Circulation 79 1989 I3 I12
15. E. Bennett-Guerrero, L. Ayuso, C. Hamilton-Davies Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery JAMA 277 1997 646 650
16. I.J. Welsby, E. Bennett-Guerrero, D. Atwell The association of complication type with mortality and prolonged stay after cardiac surgery with cardiopulmonary bypass Anesth Analg 94 2002 1072 1078
17. T.E. Warkentin, J.A. Sheppard, P. Horsewood, P.J. Simpson, J.C. Moore, J.G. Kelton Impact of the patient population on the risk for heparin-induced thrombocytopenia Blood 96 2000 1703 1708
18. R.T. Williams, L.V. Damaraju, M.A. Mascelli Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes Circulation 107 2003 2307 2312
19. B.H. Chong Heparin-induced thrombocytopenia J Thromb Haemost 1 2003 1471 1478
20. P.M. Newman, B.H. Chong Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation Blood 96 2000 182 187